DOSEN PENGAMPU :
Hery Muhamad Ansory, S.Pd., M.Sc
DISUSUN OLEH
Nama Maria Aprilia Elecsia Kaza Poto
Nim A28227166
Teori 7
Sumber https://scholar.google.com/citations?view_op=view_citation&hl=id&user=YooG
txkAAAAJ&citation_for_view=YooGtxkAAAAJ:M3ejUd6NZC8C
Daftar Bao, H., & Muge, Q. (2021). Anticancer effect of myristicin on hepatic carcinoma
Pustaka and related molecular mechanism. Pharmaceutical Biology, 59(1), 1124–
1130. https://doi.org/10.1080/13880209.2021.1961825
Kamal, A., Reddy, M. K., & Viswanath, A. (2013). The design and development
of imidazothiazole–chalcone derivatives as potential anticancer drugs.
Expert Opinion on Drug Discovery, 8(3), 289–304.
https://doi.org/10.1517/17460441.2013.758630
Kulkarni, R. R., Tupe, S. G., Gample, S. P., Chandgude, M. G., Sarkar, D.,
Deshpande, M. V., & Joshi, S. P. (2014a). Antifungal dimeric chalcone
derivative kamalachalcone E fromMallotus philippinensis. Natural
Product Research, 28(4), 245–250.
https://doi.org/10.1080/14786419.2013.843178
Luo, L., Liang, H., & Liu, L. (2021a). Myristicin regulates proliferation and
apoptosis in oxidized low-density lipoprotein-stimulated human vascular
smooth muscle cells and human umbilical vein endothelial cells by
regulating the PI3K/Akt/NF-κB signalling pathway. Pharmaceutical
Biology, 60(1), 56–64. https://doi.org/10.1080/13880209.2021.2010775
Ouyang, Y., Li, J., Chen, X., Fu, X., Sun, S., & Wu, Q. (2021). Chalcone
Derivatives: Role in Anticancer Therapy. Biomolecules, 11(6), 894.
https://doi.org/10.3390/biom11060894
Seneme, E. F., Santos, D. R. D., De Lima, C. O., Zelioli, Í. a. M., Sciani, J. M., &
Longato, G. B. (2022). Effects of Myristicin in Association with
Chemotherapies on the Reversal of the Multidrug Resistance (MDR)
Mechanism in Cancer. Pharmaceuticals, 15(10), 1233.
https://doi.org/10.3390/ph15101233